| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/13/2024 | $5.00 → $3.50 | Buy → Neutral | ROTH MKM |
SOMERSET, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology and generative AI solutions, today announced that it has transferred the funds for the January 2025 dividend payments on its Series A and Series B Cumulative Redeemable Perpetual Preferred Stock. As previously disclosed, holders of Series A Preferred Stock will receive 22.917 cents per share, while holders of Series B Preferred Stock will receive 18.229 cents per share based on a record date of January 31, 2025. These payments are expected to be reflected in shareholders' brokerage accounts between February 18 and February 20, 2025. "We appreciate the continue
Streamlining the Referral Process to Enhance Efficiency and Patient Experience SOMERSET, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology and AI-driven solutions, is proud to announce the launch of its new advanced referral module. This innovative solution is designed to simplify the referral process for medical providers and enhance the patient experience through advanced automation and location-based guidance. By optimizing referrals to specialists, the module reduces administrative time and effort, enabling a more streamlined, patient-focused approach. With its automated workflow, healthcare providers can save up to
SOC 2 Type 2 Attestation Positions CareCloud Among a Select Group of less than 10% of all EHR Vendors SOMERSET, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology and AI-driven solutions, today announced that it has successfully completed a SOC 2 Type 2 examination for the second consecutive year, receiving a clean report with no exceptions. The examination scope of the Healthcare IT systems, performed by an independent CPA firm, covered security, availability, processing integrity, and confidentiality. This accomplishment underscores the Company's commitment to the highest standards of data security, pri
Somerset, NJ, Jan. 28, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP)), a leading provider of healthcare technology and generative AI solutions for medical practices and health systems nationwide, is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025 at the Borgata Hotel Spa & Casino in Atlantic City, NJ. CareCloud's management team will deliver a corporate presentation highlighting the Company's recent developments, innovative solutions, and strategic growth initiatives. Additionally, the team will participate in one-on
SOMERSET, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP)), a leading provider of healthcare technology and generative AI solutions for medical practices and health systems nationwide, today held its special meeting ("Special Meeting") of CareCloud's common stock shareholders. At the Special Meeting, a record-breaking 10.8 million shareholders, representing 85% of the votes cast, approved an amendment to the Company's Certificate of Incorporation to increase the Company's authorized shares of common stock from 35 million to 85 million shares. "We thank our shareholders for their overwhelming support of our proposal," said Stephen Snyde
SOMERSET, N.J., Jan. 24, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company" or "CareCloud") (NASDAQ:CCLD, CCLDO, CCLDP)), a leading provider of healthcare information technology and generative AI solutions for medical practices and health systems nationwide, today announced that shareholders have tentatively approved the proposal to increase the number of authorized common shares. Approximately 10.4 million votes by proxy have been returned (the "votes") in favor of increasing the authorized number of shares of common stock from 35 million to 85 million shares, marking one of the highest levels of positive votes in the Company's history. The votes in favor represent over 80% of the t
Accelerated Timeline Reflects Strong Financial Performance and Commitment to Shareholder Value SOMERSET, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare information technology and generative AI solutions for medical practices and health systems nationwide, today announced that its Board of Directors (the "Board") has decided to resume dividend payments on its Series A Cumulative Redeemable Perpetual Preferred Stock (the "Series A Preferred Stock") and Series B Cumulative Redeemable Perpetual Preferred Stock (the "Series B Preferred Stock") earlier than previously announced based on the Company's success at accel
SOMERSET, N.J., Jan. 06, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that approximately 94% of the shares represented by proxies submitted to-date for the common stock special meeting scheduled for January 27, 2025 (the "Special Meeting") have voted "FOR" the Board-supported proposal to increase the number of authorized shares (the "Proposal"). The Proposal seeks to increase the Company's authorized common stock to provide greater strategic flexibility. The additional shares will enable CareCloud to pursue future acquisitions, support
Focused on Accelerating Technology Innovation, Revenue Growth, and Enhancing Client Experience SOMERSET, N.J., Dec. 16, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDP, CCLDO)), a leading provider of healthcare technology and generative AI solutions for medical practices and health systems nationwide, today announced a strategic realignment of its leadership team, effective January 1, 2025. A. Hadi Chaudhry and Stephen Snyder will serve as Co-CEOs, with Crystal Williams appointed as President. "We are thrilled to announce these important leadership changes," said Mahmud Haq, Founder and Executive Chairman of CareCloud's Board of Directors. "As we look ahead to 2025, our focu
SOMERSET, N.J., Dec. 09, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company" or "CareCloud") (NASDAQ:CCLD, CCLDP)), a leader in healthcare information technology solutions for medical practices and health systems nationwide, today announced the solicitation of proxies from its common stock (the "Common Stock") shareholders to approve an increase in its authorized shares. This increase is designed to support the Company's growth initiatives and corporate objectives. Focus on Growth Mahmud Haq, Founder and Executive Chairman of CareCloud's Board of Directors stated, "As CareCloud's largest common stockholder, Founder and Executive Chairman, I enthusiastically support this proposal. Our
ROTH MKM downgraded CareCloud from Buy to Neutral and set a new price target of $3.50 from $5.00 previously
SOMERSET, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology and generative AI solutions, today announced that it has transferred the funds for the January 2025 dividend payments on its Series A and Series B Cumulative Redeemable Perpetual Preferred Stock. As previously disclosed, holders of Series A Preferred Stock will receive 22.917 cents per share, while holders of Series B Preferred Stock will receive 18.229 cents per share based on a record date of January 31, 2025. These payments are expected to be reflected in shareholders' brokerage accounts between February 18 and February 20, 2025. "We appreciate the continue
Accelerated Timeline Reflects Strong Financial Performance and Commitment to Shareholder Value SOMERSET, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare information technology and generative AI solutions for medical practices and health systems nationwide, today announced that its Board of Directors (the "Board") has decided to resume dividend payments on its Series A Cumulative Redeemable Perpetual Preferred Stock (the "Series A Preferred Stock") and Series B Cumulative Redeemable Perpetual Preferred Stock (the "Series B Preferred Stock") earlier than previously announced based on the Company's success at accel
Pays Off Credit Line, Plans to Resume Preferred Dividends in Q1 2025 SOMERSET, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced financial and operational results for the quarter ended September 30, 2024 including that it has fully paid its credit line and that it plans to resume dividends on its Series A and B Preferred Stock on March 15, 2025. The Company's management will conduct a conference call with related slides today at 8:30 a.m. Eastern Time to discuss these results and management's outlook for the year.
SOMERSET, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO, CCLDP))), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, will release its financial results for the quarter ended September 30, 2024 before the market opens on Tuesday, November 12, 2024. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation slides can be accessed at ir.carecloud.com/events. An audio-only option is available by dialing 201-389-0920 and referencing "CareCloud Third Quarter 2024 Earnings Call." Investors who opt for audio-on
SOMERSET, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP))), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that while proxy vote solicitation continues, it has already obtained approximately 99% of the minimum required "FOR" votes by proxy in support of the amendment to the Company's Certificate of Designations, Preferences and Rights of its Series A Preferred Stock (the "Preferred Stock Proposal"). As of today, the Company has supportive proxy indications from more than 2.97 million shares and believes that it is quickly approaching the required 3.02 million share thr
SOMERSET, N.J., Aug. 23, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP))), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that approximately 89% of the shares represented by proxies returned to-date for the Series A Preferred Stock special meeting ("Special Meeting") have indicated that they are voting "FOR" the amendment to the Company's Certificate of Designations, Preferences and Rights of its Series A Preferred Stock (the "Preferred Stock Proposal"). Due to the significantly narrowed gap for passage of the Preferred Stock Proposal, the Special Meeting will be reconvened on Wednesday,
Continued Focus on Profitability and Free Cash Flow SOMERSET, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO, CCLDP))), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced financial and operational results for the quarter ended June 30, 2024. The Company's management will conduct a conference call with related slides today at 8:30 a.m. Eastern Time to discuss these results and management's outlook for the year. Second Quarter 2024 Highlights GAAP net income of $1.7 million, compared to a net loss of $1.8 million in Q2 2023Adjusted net income of $3.0 million, or $0.18 per sh
SOMERSET, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP))), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that Glass Lewis, a leading proxy voting advisory firm, has analyzed CareCloud's Series A Preferred Stock Proposals (the "Preferred Stock Proposals") and recommends a "yes" vote for the proposals at the upcoming special meeting of the holders of CareCloud's 11% Series A Cumulative Redeemable Perpetual Preferred Stock ("Series A Preferred Shareholders"). "We recommend that shareholders vote FOR [the Preferred Stock Proposals]," concluded Glass Lewis in its report da
SOMERSET, N.J., Aug. 06, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP))), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced the continuation of proxy solicitation from the holders (the "Series A Preferred Shareholders") of its 11% Series A Cumulative Redeemable Perpetual Preferred Stock (the "Series A Preferred Stock") to approve an amendment to the Company's Certificate of Designations, Preferences and Rights of its Series A Preferred Stock (the "Preferred Stock Proposal"). With approximately 38% of the shares of Series A Preferred Stock having already returned their proxies as of August
SOMERSET, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO, CCLDP))), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, will release its financial results for the quarter ended June 30, 2024 before the market opens on Tuesday, August 13, 2024. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation slides can be accessed at ir.carecloud.com/events. An audio-only option is available by dialing 201-389-0920 and referencing "CareCloud Second Quarter 2024 Earnings Call." Investors who opt for audio-only wil
SOMERSET, N.J., Dec. 04, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDP, CCLDO))), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced the appointment of Justin Pierce as its new chief sales officer (CSO). In this role, Pierce will be responsible for driving sustainable revenue growth and enhancing CareCloud's position in the rapidly evolving healthcare landscape. Pierce brings more than two decades of experience in the healthcare technology and services industry, having held leadership positions at Azalea Health, abeo, and Ventra Health. Throughout his career, he has consistently demonstrated his ability to forge
SOMERSET, N.J., July 11, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDP, CCLDO))), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced the appointment of Larry Steenvoorden as the new chief financial officer (CFO). With a distinguished career and extensive financial and strategic expertise, Steenvoorden brings valuable experience from his previous roles. Before joining CareCloud, he served as the executive vice president and CFO at Chembio Diagnostics, where he implemented strategic initiatives and improved profitability. Steenvoorden has also held CFO positions in healthcare, life science, and med-tech companies,
Bill Korn appointed chief strategy officer, Joseph DosSantos joins as chief financial officer, strengthening CareCloud's position as a leader in healthcare technology solutions. SOMERSET, N.J., May 08, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDP, CCLDO))), a leader in healthcare technology solutions for medical practices and health systems nationwide, announced today a leadership transition. Bill Korn, who has been CareCloud's chief financial officer (CFO) for 10 years, will take on a new role as chief strategy officer (CSO). The company has hired Joseph C. DosSantos, an experienced financial executive in the biotechnology sector, to fill the position of chief financial o
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
8-K - CareCloud, Inc. (0001582982) (Filer)
8-K - CareCloud, Inc. (0001582982) (Filer)
8-K - CareCloud, Inc. (0001582982) (Filer)
DEFA14A - CareCloud, Inc. (0001582982) (Filer)
8-K - CareCloud, Inc. (0001582982) (Filer)
DEFA14A - CareCloud, Inc. (0001582982) (Filer)
8-K - CareCloud, Inc. (0001582982) (Filer)
DEFA14A - CareCloud, Inc. (0001582982) (Filer)
DEF 14A - CareCloud, Inc. (0001582982) (Filer)
PRER14A - CareCloud, Inc. (0001582982) (Filer)